Long-term risk for acute pancreatitis, cholangitis, and malignancy more than 15 years after endoscopic sphincterotomy: a population-based study

Background and study aims: It has been suggested that endoscopic sphincterotomy predisposes a patient to cholangitis, pancreatitis, and carcinoma in the pancreaticobiliary tract in the long term. Previous studies have shown an increased risk for acute cholangitis and pancreatitis but not for carcinoma. The aim of this study was to analyze these risks by conducting a long-term follow-up study of patients who underwent treatment for gallstone disease, comparing patients who underwent endoscopic sphincterotomy with those who did not.

Patients and methods: A cohort of 1113 Swedish patients who were treated with endoscopic sphincterotomy between 1977 and 1990 for common bile duct stones was compared with two age-and sex-matched control groups with a history of cholecystectomy or cholecystectomy and cholangiotomy.

Results: Over a median follow-up of more than 15 years after endoscopic sphincterotomy, the hazard ratio for endoscopic sphincterotomy versus cholecystectomy was 5.5 (95 % confidence interval [CI] 3.5 – 8.4) for cholangitis and 4.9 (95 %CI 2.8 – 8.6) for pancreatitis. The hazard ratio for endoscopic sphincterotomy versus cholangiotomy was 1.7 (95 %CI 1.3 – 2.4) for cholangitis and 1.5 (95 %CI 1.0 – 2.4) for pancreatitis. There was no significant increase in risk for malignant diagnoses.

Conclusion: Patients who underwent endoscopic sphincterotomy for choledocholithiasis had an increased risk for acute pancreatitis and cholangitis in the long term compared with those not treated with endoscopic sphincterotomy. There was no increase in risk for malignancy in the pancreaticobiliary tract.

• References

• 1 Classen M, Demling L. Endoskopische sphincterotomie der papilla vateri und steinextraktion aus ductus choledochus. Dtsch Med Wochenschr 1974; 99: 496-497
• 2 Langerth A, Brandt L, Ekbom A et al. Late complications following endoscopic sphincterotomy for choledocholithiasis: a Swedish population-based study. Diagn Ther Endosc 2014; 2014: 745790
• 3 Prat F, Malak NA, Pelletier G et al. Biliary symptoms and complications more than 8 years after endoscopic sphincterotomy for choledocholithiasis. Gastroenterology 1996; 110: 894-899
• 4 Costamagna G, Tringali A, Shah SK et al. Long-term follow-up of patients after endoscopic sphincterotomy for choledocholithiasis, and risk factors for recurrence. Endoscopy 2002; 34: 273-279
• 5 Wojtun S, Gil J, Gietka W et al. Endoscopic sphincterotomy for choledocholithiasis: a prospective single-center study on the short-term and long-term treatment results in 483 patients. Endoscopy 1997; 29: 258-265
• 6 Sugiyama M, Atomi Y. Follow-up of more than 10 years after endoscopic sphincterotomy for choledocholithiasis in young patients. Br J Surg 1998; 85: 917-921
• 7 Tanaka M, Takahata S, Konomi H et al. Long-term consequence of endoscopic sphincterotomy for bile duct stones. Gastrointest Endosc 1998; 48: 465-469
• 8 Karlson BM, Ekbom A, Arvidsson D et al. Population-based study of cancer risk and relative survival following sphincterotomy for stones in the common bile duct. Br J Surg 1997; 84: 1235-1238
• 9 Mortensen FV, Jepsen P, Tarone RE et al. Endoscopic sphincterotomy and long-term risk of cholangiocarcinoma: a population-based follow-up study. J Natl Cancer Inst 2008; 100: 745-750
• 10 Strömberg C, Luo J, Enochsson L et al. Endoscopic sphincterotomy and risk of malignancy in the bile ducts, liver and pancreas. Clin Gastroenterol Hepatol 2008; 6: 1049-1053
• 11 Berthiaume EP, Wands J. The molecular pathogenesis of cholangiocarcinoma. Semin Liver Dis 2004; 24: 127-137
• 12 Malhi H, Gores GJ. Cholangiocarcinoma: modern advances in understanding a deadly old disease. J Hepatol 2006; 45: 856-867
• 13 Lowenfels AB, Maisonneuve P, Cavallini G et al. Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group. NEJM 1993; 328: 1433-1437
• 14 Pinho AV, Chantrill L, Rooman I. Chronic pancreatitis: a path to pancreatic cancer. Cancer Lett 2014; 345: 203-209
• 15 Ludvigsson JF, Otterblad-Olausson P, Pettersson BU et al. The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research. Eur J Epidemiol 2009; 24: 659-667
• 16 Ludvigsson JF, Andersson E, Ekbom A et al. External review and validation of the Swedish national inpatient register. BMC Public Health 2011; 11: 450 Available at: http://www.socialstyrelsen.se/english
• 17 Targarona EM, Ayuso RM, Bordas JM et al. Randomised trial of endoscopic sphincterotomy with gallbladder left in situ versus open surgery for common bileduct calculi in high-risk patients. Lancet 1996; 347: 926-929
• 18 Boerma D, Schwartz MP. Management of common bile-duct stones and associated gallbladder stones: surgical aspects. Best Pract Res Clin Gastroenterol 2006; 20: 1103-1116
• 19 Aiura K, Kitagawa Y. Current status of endoscopic papillary balloon dilation for the treatment of bile duct stones. J Hepatobiliary Pancreat Sci 2011; 18: 339-345
• 20 Kamisawa T, Okamoto A. Biliopancreatic and pancreatobiliary refluxes in cases with and without pancreaticobiliary maljunction: diagnosis and clinical implications. Digestion 2006; 73: 228-236
• 21 Sun S, Wu S, Cui D et al. Sphincter of Oddi manometry by choledochoscope in patients with duodenobiliary reflux. J Gastroenterol Hepatol 2011; 26: 1252-1255
• 22 Gregg JA and Carr-Locke, Carr-Locke DL. Endoscopic pancreatic and biliary manometry in pancreatic, biliary, and papillary disease, and after endoscopic sphincterotomy and surgical sphincteroplasty. Gut 1984; 25: 1247-1254
• 23 Haratake J, Horie A, Takeda N. Cancer of the intra-pancreatic common bile duct observed 9 years after choledochostomy. Gan No Rinsho 1983; 29: 1367-1370
• 24 Mantovani A, Allavena P, Sica A et al. Cancer-related inflammation. Nature 2008; 454: 436-444
• 25 Søgaard KK, Erichsen R, Lund JL et al. Cholangitis and subsequent gastrointestinal cancer risk: a Danish population-based cohort study. Gut 2014; 63: 356-361